Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor α therapy

Jing Cui, Saedis Saevarsdottir, Brian Thomson, Leonid Padyukov, Annette H M Van Der Helm-van Mil, Joanne Nititham, Laura B. Hughes, Niek De Vries, Soumya Raychaudhuri, Lars Alfredsson, Johan Askling, Sara Wedrén, Bo Ding, Candace Guiducci, Gert Jan Wolbink, J. Bart A Crusius, Irene E. Van Der Horst-Bruinsma, Marieke Herenius, Michael E. Weinblatt, Nancy A. ShadickJane Worthington, Franak Batliwalla, Marlena Kern, Ann W. Morgan, Anthony G. Wilson, John D. Isaacs, Kimme Hyrich, Michael F. Seldin, Larry W. Moreland, Timothy W. Behrens, Cornelia F. Allaart, Lindsey A. Criswell, Tom W J Huizinga, Paul P. Tak, S. Louis Bridges, Rene E M Toes, Anne Barton, Lars Klareskog, Peter K. Gregersen, Elizabeth W. Karlson, Robert M. Plenge

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor α therapy'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Nursing and Health Professions

    Immunology and Microbiology

    Pharmacology, Toxicology and Pharmaceutical Science

    Neuroscience